Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is Poolbeg Pharma PLC a Promising Long-Term Healthcare Investment?

Poolbeg Pharma PLCis a clinical-stage biopharmaceutical company focused on developing innovative therapies for infectious diseases, cancer immunotherapy-related conditions, and metabolic disorders. The company has attracted growing investor interest due to its diversified pipeline, artificial intelligence-driven drug discovery platform, and advancement of POLB 001, its …

Ishan Mudgal | 14 May 2026

Are Funding Concerns Dragging LSE:COIL Lower?

Coiled Therapeutics Plc(LSE:COIL) is a biotechnology company focused on developing advanced therapeutic platforms and innovative healthcare solutions. The company operates within the life sciences and biopharmaceutical sector, where valuations are largely driven by research progress, clinical development milestones, intellectual property strength, and long-term commercial …

Divya Sood | 14 May 2026

Could Scancell Holdings Plc Benefit From the Growing Immunotherapy Market?

Scancell Holdings Plcis a UK-based clinical-stage biotechnology company focused on developing immunotherapies and cancer vaccines using its proprietary ImmunoBody®, Moditope®, GlyMab®, and AvidiMab® platforms. The company has attracted growing investor attention due to encouraging clinical trial developments in melanoma and other solid tumour indications.

Ishan Mudgal | 14 May 2026

Is EDX Medical Group PLC a High-Growth Healthcare Stock to Watch?

EDX Medical Group PLCis an emerging healthcare diagnostics company focused on developing innovative digital diagnostic products and services for cancer, cardiovascular disease, and infectious diseases. The company has attracted increasing market attention due to its growing pipeline of advanced cancer detection solutions, strategic partnerships, …

Ishan Mudgal | 14 May 2026

Is Now the Right Time to Watch Spire Healthcare Stock?

Why Is SPI - Spire Healthcare Stock Rising Today in May 2026?

Ankur Sharma | 14 May 2026

Can Arecor Therapeutics PLC Capitalise on Oral GLP-1 Innovation?

Arecor Therapeutics PLCis a UK-based biopharmaceutical company focused on developing enhanced formulations and delivery systems for existing therapeutic products. The company primarily operates in diabetes and cardiometabolic disease markets while leveraging its proprietary Arestat™ formulation technology platform.

Ishan Mudgal | 13 May 2026

Can Diagnostics Innovation Drive Proteome Sciences Growth?

Why Is PRM - Proteome Sciences Stock Rising Today in May 2026?

Ankur Sharma | 13 May 2026

What’s Driving the Surge in Coiled Therapeutics Shares?

Coiled Therapeutics PLC(LSE:COIL) has moved higher in today’sTrading session, reflecting renewed investor interest in biotechnology and early-stage healthcare innovation companies. The company is focused on developing therapeutic technologies targeting unmet medical needs, positioning itself within the high-growth biotech sector. LSE:COIL appears to be benefiting …

Divya Sood | 13 May 2026

Is Cambridge Nutritional Sciences a High-Risk High-Reward Healthcare Play?

Why Is CNSL - Cambridge Nutritional Sciences Stock Falling Today in May 2026?

Ankur Sharma | 13 May 2026

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions